A clinical trial funded by Juul purports to show that switching to the company’s e-cigarette products reduces the risk of toxins in a similar manner to stopping smoking altogether
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.